GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (XTER:FRE) » Definitions » Median PS Value

Fresenius SE KGaA (XTER:FRE) Median PS Value : €46.56 (As of May. 01, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Fresenius SE KGaA Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Fresenius SE KGaA's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €57.444. Fresenius SE KGaA's 10-Year median PS Ratio is 0.8105. Therefore, the Median PS Value for today is €46.56.

As of today (2024-05-01), Fresenius SE KGaA's share price is €27.97. Fresenius SE KGaA's Median PS Value is €46.56. Therefore, Fresenius SE KGaA's Price to Median PS Value for today is 0.60.

The historical rank and industry rank for Fresenius SE KGaA's Median PS Value or its related term are showing as below:

XTER:FRE' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.54   Med: 0.63   Max: 0.88
Current: 0.6

During the past 13 years, the highest Price to Median PS Value of Fresenius SE KGaA was 0.88. The lowest was 0.54. And the median was 0.63.

XTER:FRE's Price-to-Median-PS-Value is ranked better than
68.51% of 235 companies
in the Healthcare Providers & Services industry
Industry Median: 0.74 vs XTER:FRE: 0.60

Fresenius SE KGaA Median PS Value Historical Data

The historical data trend for Fresenius SE KGaA's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA Median PS Value Chart

Fresenius SE KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 56.61 58.08 60.04 48.62 46.56

Fresenius SE KGaA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.62 49.09 50.37 50.56 46.56

Competitive Comparison of Fresenius SE KGaA's Median PS Value

For the Medical Care Facilities subindustry, Fresenius SE KGaA's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius SE KGaA's Price-to-Median-PS-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's Price-to-Median-PS-Value falls into.



Fresenius SE KGaA Median PS Value Calculation

Fresenius SE KGaA's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=57.444*0.8105
=46.56

10-Year Median PS Ratio is 0.8105.
Fresenius SE KGaA's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €57.444.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fresenius SE KGaA  (XTER:FRE) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Fresenius SE KGaA's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=27.97/46.56
=0.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fresenius SE KGaA Median PS Value Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius SE KGaA (XTER:FRE) Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.
Executives
Dr. Michael Moser Board of Directors
Sara Hennicken Board of Directors
Michael Sen Board of Directors
Dr. Francesco De Meo Board of Directors
Stephan Sturm Board of Directors
Wolfgang Kirsch Supervisory Board
Mats Henriksson Board of Directors
Dr. Gerd Krick Supervisory Board

Fresenius SE KGaA (XTER:FRE) Headlines

No Headlines